TGF-β expression by allogeneic bone marrow stromal cells ameliorates diabetes in NOD mice through modulating the distribution of CD4+ T cell subsets

2008 ◽  
Vol 253 (1-2) ◽  
pp. 23-30 ◽  
Author(s):  
Wei Zhao ◽  
Yan Wang ◽  
Dandan Wang ◽  
Bo Sun ◽  
Guangyou Wang ◽  
...  
Cytotherapy ◽  
2011 ◽  
Vol 13 (5) ◽  
pp. 562-571 ◽  
Author(s):  
Laura Otero ◽  
Mercedes Zurita ◽  
Celia Bonilla ◽  
Concepcion Aguayo ◽  
Angela Vela ◽  
...  

2000 ◽  
Vol 69 (11) ◽  
pp. 2366-2373 ◽  
Author(s):  
Andreas Heitger ◽  
Hildegard Greinix ◽  
Christine Mannhalter ◽  
Doris Mayerl ◽  
Hannelore Kern ◽  
...  

Blood ◽  
2000 ◽  
Vol 95 (12) ◽  
pp. 3758-3764 ◽  
Author(s):  
Anne Solanilla ◽  
Julie Déchanet ◽  
Abdel El Andaloussi ◽  
Moryse Dupouy ◽  
François Godard ◽  
...  

Abstract CD40 ligand (CD40L)/CD40 interactions play a central role in T-cell–dependent B-cell activation as previously shown by in vitro studies, the phenotype of CD40L knockout mice and the defective expression of CD40L in patients who have X-linked immunodeficiency with hyper-IgM. The distribution of CD40 in cells other than of myeloid and lymphoid lineages has suggested additional functions for this receptor/ligand couple. Here we show that CD40L stimulates myelopoiesis with a noticeable effect on megakaryocytopoiesis in cocultures of hematopoietic progenitor cells and bone marrow stromal cells. These results suggest a mechanism by which T-cell or platelet-associated or soluble CD40L may regulate myelopoiesis.


Sign in / Sign up

Export Citation Format

Share Document